Literature DB >> 326459

Diuretic therapies in low renin and normal renin essential hypertension.

C S Brooks, C A Johnson, J M Kotchen, T A Kotchen.   

Abstract

This study was designed to compare the effectiveness of spironolactone, hydrochlorothiazide, and combined spironolactone-hydrochlorothiazide therapy in patients with low renin and those with normal renin essential hypertension. Patients with low renin hypertension had a greater hypotensive response to each regimen (p less than 0.001). Low renin patients responded equally to both spironolactone and to hydrochlorothiazide, and in low renin but not in normal renin patients reduction of blood pressure correlated with weight loss. These results suggest that a volume factor, not specifically related to increased mineralocorticoid production, contributes to the pathogenesis of low renin essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 326459     DOI: 10.1002/cpt197722114

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  4 in total

Review 1.  Personalizing the diuretic treatment of hypertension: the need for more clinical and research attention.

Authors:  Samuel J Mann; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

2.  The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.

Authors:  C Lucas; P Jenkins; J Mendels; D Due; W P Forbes; M A Sirgo
Journal:  J Natl Med Assoc       Date:  1991-10       Impact factor: 1.798

3.  Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.

Authors:  J H Kreeft; P Larochelle; R I Ogilvie
Journal:  Can Med Assoc J       Date:  1983-01-01       Impact factor: 8.262

Review 4.  Drug therapy for resistant hypertension: simplifying the approach.

Authors:  Samuel J Mann
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-11-08       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.